Stiff Person Syndrome (SPS) is a complex autoimmune neurological disorder, and unlocking its mechanisms is key to developing new therapies. Research progress depends on having access to biologically relevant, reliable laboratory models.
At Creative Biolabs, we specialize in developing physiologically relevant cell models that empower researchers to explore the pathophysiology of SPS with greater precision. Our suite of SPS cell models provides the robust tools you need to investigate GABAergic neurotransmission, screen novel immunotherapies, and push the boundaries of neurological science. Contact our team of scientific experts to begin a dialogue about your unique project. Whether you have a fully-formed research plan or an early-stage concept, share your objectives with us. We will collaborate with you to design a tailored experimental strategy and provide a comprehensive proposal that includes a detailed scope, timeline, and transparent pricing.
For a detailed enumeration of our specific offerings, please consult our comprehensive Product List.
We offer a tiered selection of models to meet every research need and budget.
Types | Description |
---|---|
GAD65-Expressing Neuronal Lines | Engineered cell lines that stably overexpress glutamic acid decarboxylase 65 (GAD65), the primary autoantigen in classic SPS. |
GABAergic Neuron Models | Models designed to replicate the impaired inhibitory GABAergic neurotransmission central to SPS pathology. |
Glycine Receptor (GlyR) Mutant Models | Cell lines incorporating mutations or antibody targets in the glycine-alpha 1 receptor, relevant for SPS variants. |
Paraneoplastic Antigen Models | Models expressing antigens like amphiphysin, crucial for studying paraneoplastic SPS associated with certain cancers. |
Custom iPSC-Derived Neurons | Development of patient-specific iPSC lines that can be differentiated into GABAergic neurons or other relevant cell types, offering a powerful tool for personalized medicine research. |
Choosing our SPS cell models gives your research a significant edge.
Bypass the time-consuming and costly process of developing models from scratch. Our validated, off-the-shelf and custom models let you focus on your primary research questions.
By mirroring the impaired GABAergic pathways and autoimmune targets seen in patients, our models provide more predictive data for therapeutic development.
Reduce experimental variability with highly characterized and standardized cell lines, leading to more reliable and publishable results.
Leverage our two decades of experience in complex cell model development. Our scientific team is available to provide support and help you select the perfect model for your study.
Our SPS cell models are versatile tools suitable for a wide range of applications:
Applications | Description |
---|---|
High-Throughput Drug Screening | Efficiently screen compound libraries to identify novel GABA-enhancing agents or senomorphics. |
Immunotherapy Efficacy Testing | Evaluate the mechanism of action and efficacy of potential immunotherapies like IVIg, rituximab, and next-generation anti-B-cell agents. |
Pathophysiology Studies | Investigate the functional consequences of anti-GAD and other autoantibodies on neuronal health and GABAergic signaling. |
Biomarker Discovery | Use models to identify new diagnostic or prognostic biomarkers associated with SPS disease progression. |
Toxicity and Safety Profiling | Assess the potential neurotoxicity of drug candidates in a relevant biological context. |
At Creative Biolabs, we are committed to providing the scientific community with the highest quality tools and services. Our Stiff Person Syndrome cell models are developed and validated by leading scientists to ensure you get reliable, reproducible, and translatable data. Move your research forward with confidence.
Contact us today to discuss your project with one of our specialists and learn how our advanced SPS models can help you achieve your research goals.
For more categories of Neuromuscular & Genetic Disease related Research Tools, please visit the following link:
Reference